San Leon Energy's Chairman, Oisin Fanning, has purchased one million shares in the company less than a week after the oil and gas explorer reported strong results from Poland.
Fanning purchased the shares at 8.63p for £86,300, taking his stake in the company to 60.84m shares 5.33%.
The firm unveiled a positive set of initial results from the Siciny-2 well in Poland, saying it has proved the 'huge upside potential' of the carboniferous basin.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
The firm said it encountered continuous gas shows throughout the well and that based on the results of the analysis of the core, it has been able to deterine the quality of five prospective zones for unconventional gas accumulations.
In zone 1,151 metres of net oil pay was indentified, resulting in a free gas in place estimate of 163bn cubic feet (bcf) and a total gas estimate of 193 bcf.
Top Director Buys
Land Securities Group (LAND)
Director name: Mr Robert Noel
Amount purchased: 80,000 @ 743.67p
Value: £594,936
Pentagon Protection (PPR)
Director name: Mr Haytham ElZayn
Amount purchased: 2,000,000 @ 5.50p
Value: £110,000
San Leon Energy (SLE)
Director name: Mr Oisin Fanning
Amount purchased: 1,000,000 @ 8.63p
Value: £86,300
Daisy Group (DAY)
Director name: Mr Steve Smith
Amount purchased: 78,527 @ 95.00p
Value: £74,601
Yule Catto & Co (YULC)
Director name: Mr Neil A Johnson
Amount purchased: 50,000 @ 138.30p
Value: £69,150
GlaxoSmithKline (GSK)
Director name: Sir Sir Deryck Maughan
Amount purchased: 1,819 @ 1,444.35p
Value: £26,273
GlaxoSmithKline (GSK)
Director name: Mr Lawrence Culp
Amount purchased: 1,819 @ 1,444.35p
Value: £26,273
GlaxoSmithKline (GSK)
Director name: Dr Dr Dan Podolsky
Amount purchased: 1,754 @ 1,444.35p
Value: £25,334
GlaxoSmithKline (GSK)
Director name: Sir Sir Christopher Gent
Amount purchased: 2,321 @ 1,454.00p
Value: £33,747
GlaxoSmithKline (GSK)
Director name: Sir Sir Crispin H L Davis
Amount purchased: 2,149 @ 1,454.00p
Value: £31,246
-
FTSE 100 hits record highs – why is it rising and will we see more gains?Advice UK equities have been described as unloved for a long time but as the FTSE 100 hits new highs, we explain if now is the time to buy British.
-
How to invest in copperIt may be time to invest in copper as the red metal appears poised for a big jump. Dominic Frisby looks at what should investors should buy
